Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

Global Cannabis Protest in Bogota Calls for Legalization and Rights

Regulations by 2FIRSTS.ai
May.06.2024
Global Cannabis Protest in Bogota Calls for Legalization and Rights
Colombians in Bogota demand decriminalization and legalization of marijuana at global rally on May 4, reports EFE News Agency.

According to a report from the EFE news agency on May 5th, in Bogota, Colombia, a global marijuana march was held on May 4th. Participants in the march called for the complete decriminalization of marijuana use and sales, and demanded the legalization of marijuana cultivation, whether for medical or recreational purposes.

 

Another important aspect of the appeal is the legalization of personally grown marijuana, regardless of its intended use for medical or recreational purposes. They believe that everyone should have the right to freedom of choice, and current discriminatory laws do not adhere to principles of fairness.

 

In this global marijuana march, participants strongly urge for the complete lifting of criminal penalties for the use and sale of marijuana. Marijuana consumers gathered in the Colombian capital, Bogota, actively organizing protest activities to fight for their rights.

 

References:
[1] Colombia: Marcha mundial por la legalización de la marihuana
Also Read:
[1] U.S. Drug Enforcement Administration Plans to Reclassify Marijuana
[2] North Dakota Organization Pushes for Legalization of Recreational Marijuana
[3] Argentinian Massive Protest against Government Crackdown on Cannabis Registration Organization
#Legislation#CBD#South America#Colombia#Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
Nicotine pouches, promoted as flavored, smoke-free alternatives, are spreading in Uruguay despite the absence of a formal market. The Ministry of Public Health is considering banning them by decree and has raised the issue within Mercosur and at COP11. Health Minister Cristina Lustemberg warns that the industry is pushing new nicotine products to normalize consumption among youth.
Nov.20 by 2FIRSTS.ai
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan unveils limited edition IQOS ILUMA i in Galaxy Blue, inspired by the universe, set to launch on October 29.
Oct.14 by 2FIRSTS.ai
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Thailand Chonburi provincial police, in coordination with multiple agencies, raided a large-scale warehouse in downtown Chonburi used for producing and distributing e-cigarettes and vape liquids. Two Chinese nationals were arrested, and more than 40 categories of contraband—including vapes, e-liquids, and production equipment—were seized, with an estimated total value exceeding US$920,000 (about 30 million Thai baht).
Nov.17 by 2FIRSTS.ai
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia's Q3 results show a sharp 89.5% drop in net profit to RM7 million (approximately $150,000 USD), with revenue also falling to RM300 million (approximately $6.4 million USD). The company attributed the decline to new regulatory requirements, including pictorial health warnings and the retail display ban. Its stock dropped 15.25% to RM4.78 (approximately $1.02 USD).
Oct.31 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Related Topics
News Regulation
Related Read
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
2FIRSTS.ai
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
2FIRSTS.ai
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
2FIRSTS.ai
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
2FIRSTS.ai
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文